The introduction of these additional licensing options is PDS' take on providing a service that allows pharmaceutical companies and CROs to use the software without having to pay upfront costs. http://crolegacy.com/ofloxacin-for-injection-pharmaceutical-outsourcing-project-find-cro-contract-research-organization.html
Software provider, PDS Pathology Data Systems have announced it can now provide Internet access to its specialised post-mortem functionality system to users that include University research departments, CROs, Biotechs and smaller Toxicology and Pathology work groups.
In addition, these companies can incorporate a pay-as-they-go system without impacting their capital budgets.
The PathData software system is used for preclinical pathology, offering users post-mortem functionalities from necropsy and histology to microscopy, statistics, tables, peer review, imaging and FDA-compliant final report generation. Computer puzzle game for lack of evidence to protect the brain
"Not only are research universities and CROs enthused about being able to utilise the same powerful and flexible mission-critical software that is used by 7 of the 10 Top-Ten Pharma companies but, interestingly enough, so are biotech companies," said Arthur Karakos, CEO of the vendor's North America marketing and support group, >Pathology Data Solutions.
The ante-mortem aspects are backed up by the company's ToxData System for toxicology and clinical pathology and the new ReproData System for reproductive toxicology and teratology.